UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Estimated Number of Symptomatic Lyme Borreliosis Cases in Adults in Finland in 2021 Using Seroprevalence Data to Adjust the Number of Surveillance-Reported Cases: A General Framework for Accounting for Underascertainment by Public Health Surveillance

Vector borne and zoonotic diseases (Larchmont, N.Y.), 2023-04, Vol.23 (4), p.265-272

2023

Volltextzugriff (PDF)

Exploring the costs of a 13-valent pneumococcal conjugate vaccination program for home care patients

Current medical research and opinion, 2018-12, Vol.34 (12), p.2089-2094

2018

Volltextzugriff (PDF)

Concentration and High Avidity of Pneumococcal Antibodies Persist at Least 4 Years after Immunization with Pneumococcal Conjugate Vaccine in Infancy

Clinical and Vaccine Immunology, 2013-07, Vol.20 (7), p.1034-1040

2013

Volltextzugriff (PDF)

Invasive pneumococcal disease among the elderly in the later era of paediatric pneumococcal conjugate vaccination-A longitudinal study over 10 years based on public surveillance data in the Nordics

PloS one, 2023-06, Vol.18 (6), p.e0287378-e0287378

2023

Volltextzugriff (PDF)

Economic impact of 13-valent pneumococcal conjugate vaccine in Finnish adults ≥50 years with underlying chronic medical conditions

Journal of evaluation in clinical practice, 2014-08, Vol.20 (4), p.333-341

2014

Volltextzugriff (PDF)

Protective Efficacy of a Second Pneumococcal Conjugate Vaccine against Pneumococcal Acute Otitis Media in Infants and Children: Randomized, Controlled Trial of a 7-Valent Pneumococcal Polysaccharide-Meningococcal Outer Membrane Protein Complex Conjugate Vaccine in 1666 Children

Clinical infectious diseases, 2003-11, Vol.37 (9), p.1155-1164

2003

Volltextzugriff (PDF)

Estimating the Impact of Switching from a Lower to Higher Valent Pneumococcal Conjugate Vaccine in Colombia, Finland, and The Netherlands: A Cost-Effectiveness Analysis

Infectious diseases and therapy, 2020-06, Vol.9 (2), p.305-324

2020

Volltextzugriff (PDF)

Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine

The Pediatric infectious disease journal, 2001-01, Vol.20 (1), p.25-33

2001

Volltextzugriff (PDF)

Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age

The Pediatric infectious disease journal, 2005-02, Vol.24 (2), p.108-114

2005

Volltextzugriff (PDF)

Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children

The Journal of infectious diseases, 1995-11, Vol.172 (5), p.1273-1278

1995

Volltextzugriff (PDF)

Kinetics and Avidity of Antibodies Evoked by Heptavalent Pneumococcal Conjugate Vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial

Infection and Immunity, 2005, Vol.73 (1), p.369-377

2005

Volltextzugriff (PDF)

Concentration of Antipneumococcal Antibodies as a Serological Correlate of Protection: An Application to Acute Otitis Media

The Journal of infectious diseases, 2004-08, Vol.190 (3), p.545-550

2004

Volltextzugriff (PDF)

Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT

Vaccine, 2001-10, Vol.20 (1), p.194-201

2001

Volltextzugriff (PDF)

Antigenically Diverse Reference Strains and Autologous Strains of Actinobacillus actinomycetemcomitans Are Equally Efficient Antigens in Enzyme-Linked Immunosorbent Assay Analysis

Journal of Clinical Microbiology, 2002-12, Vol.40 (12), p.4640-4645

2002

Volltextzugriff (PDF)

Bridging Phase 2 and Phase 3 Pneumococcal Immunologic Data for Future Combination Vaccines

Clinical infectious diseases, 2001-12, Vol.33 (Supplement-4), p.S292-S298

2001

Volltextzugriff (PDF)

Tolerability and immunogenicity of an eleven-valent pneumococcal conjugate vaccine in healthy toddlers

The Pediatric infectious disease journal, 2001-03, Vol.20 (3), p.272-277

2001

Volltextzugriff (PDF)

TBE in Finland

Tick-borne encephalitis - The Book, 2024-05

2024

Volltextzugriff (PDF)

TBE in Finland

Tick-borne encephalitis - The Book, 2023-05

2023

Volltextzugriff (PDF)

TBE in Finland

Tick-borne encephalitis - The Book, 2022-06

2022

Volltextzugriff (PDF)

TBE in Finland

Tick-borne encephalitis - The Book, 2021-05

2021

Volltextzugriff (PDF)

Economic impact of 13‐valent pneumococcal conjugate vaccine in F innish adults ≥50 years with underlying chronic medical conditions

Journal of evaluation in clinical practice, 2014-08, Vol.20 (4), p.333-341

2014

Volltextzugriff (PDF)

Avidity of IgG for Streptococcus pneumoniae Type 6B and 23F Polysaccharides in Infants Primed with Pneumococcal Conjugates and Boosted with Polysaccharide or Conjugate Vaccines

The Journal of infectious diseases, 1998-06, Vol.177 (6), p.1614-1621

1998

Volltextzugriff (PDF)

TBE in Finland

Tick-borne encephalitis - The Book, 2019

2019

Volltextzugriff (PDF)

Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory

The Pediatric infectious disease journal, 1998-03, Vol.17 (3), p.211-216

1998

Volltextzugriff (PDF)

Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood

Vaccine, 1999-04, Vol.17 (15), p.1970-1977

1999

Volltextzugriff (PDF)

1 – 25 von 40

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(34)
Mit Volltextzugriff
(26)

Publikationsform

Artikel
(39)
Dissertationen
(1)

Sprache

Englisch
(40)

Erscheinungsjahr

n.n

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Estimated Number of Symptomatic Lyme Borreliosis Cases in Adults in Finland in 2021 Using Seroprevalence Data to Adjust the Number of Surveillance-Reported Cases: A General Framework for Accounting for Underascertainment by Public Health Surveillance

Exploring the costs of a 13-valent pneumococcal conjugate vaccination program for home care patients

Concentration and High Avidity of Pneumococcal Antibodies Persist at Least 4 Years after Immunization with Pneumococcal Conjugate Vaccine in Infancy

Invasive pneumococcal disease among the elderly in the later era of paediatric pneumococcal conjugate vaccination-A longitudinal study over 10 years based on public surveillance data in the Nordics

Economic impact of 13-valent pneumococcal conjugate vaccine in Finnish adults ≥50 years with underlying chronic medical conditions

Protective Efficacy of a Second Pneumococcal Conjugate Vaccine against Pneumococcal Acute Otitis Media in Infants and Children: Randomized, Controlled Trial of a 7-Valent Pneumococcal Polysaccharide-Meningococcal Outer Membrane Protein Complex Conjugate Vaccine in 1666 Children

Estimating the Impact of Switching from a Lower to Higher Valent Pneumococcal Conjugate Vaccine in Colombia, Finland, and The Netherlands: A Cost-Effectiveness Analysis

Serum and salivary anti-capsular antibodies in infants and children immunized with the heptavalent pneumococcal conjugate vaccine

Immunogenicity and tolerability of a heptavalent pneumococcal conjugate vaccine administered at 3, 5 and 12 months of age

Pneumococcal polysaccharide-meningococcal outer membrane protein complex conjugate vaccine is immunogenic in infants and children

Kinetics and Avidity of Antibodies Evoked by Heptavalent Pneumococcal Conjugate Vaccines PncCRM and PncOMPC in the Finnish Otitis Media Vaccine Trial

Concentration of Antipneumococcal Antibodies as a Serological Correlate of Protection: An Application to Acute Otitis Media

Serum and salivary anti-capsular antibodies in infants and children vaccinated with octavalent pneumococcal conjugate vaccines, PncD and PncT

Antigenically Diverse Reference Strains and Autologous Strains of Actinobacillus actinomycetemcomitans Are Equally Efficient Antigens in Enzyme-Linked Immunosorbent Assay Analysis

Bridging Phase 2 and Phase 3 Pneumococcal Immunologic Data for Future Combination Vaccines

Tolerability and immunogenicity of an eleven-valent pneumococcal conjugate vaccine in healthy toddlers

TBE in Finland

TBE in Finland

TBE in Finland

TBE in Finland

Economic impact of 13‐valent pneumococcal conjugate vaccine in F innish adults ≥50 years with underlying chronic medical conditions

Avidity of IgG for Streptococcus pneumoniae Type 6B and 23F Polysaccharides in Infants Primed with Pneumococcal Conjugates and Boosted with Polysaccharide or Conjugate Vaccines

TBE in Finland

Streptococcus pneumoniae capsular polysaccharide-diphtheria toxoid conjugate vaccine is immunogenic in early infancy and able to induce immunologic memory

Differences in the avidity of antibodies evoked by four different pneumococcal conjugate vaccines in early childhood

Suchergebnisse filtern